Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Izmirly

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Rheumatology|May 1, 2023
Molnupiravir and Nirmatelvir/Ritonavir in the Treatment of Patients With Systemic Autoimmune Rheumatic Disease With SARS-CoV-2Kelly Corbitt, Peter Izmirly, Amit Saxena
Current Opinion in Rheumatology|May 19, 2017
Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupusPeter Izmirly, Amit Saxena, Jill P Buyon
Journal of the American Heart Association|June 22, 2022
To Be or Not to Be Treated: That Is the Question in Managing a Fetus With Cardiac Injury Exposed to Anti-SSA/RoJill Buyon, Amit Saxena, Deborah Friedman, et al.
Arthritis Care & Research|July 9, 2016
Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data SystemAnna Broder, Wenzhu B Mowrey, Peter Izmirly, et al.
Lupus Science & Medicine|October 16, 2018
Evaluating duration of response to treatment in systemic lupus erythematosus clinical trialsMimi Kim, Joan T Merrill, Kenneth Kalunian, et al.
AJP Reports|May 11, 2023
Autoimmune Congenital Complete Heart Block: How Late Can It Occur?Luv Makadia, Peter Izmirly, Jill P Buyon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
Brief Report: Longitudinal Patterns of Response to Standard of Care Therapy for Systemic Lupus Erythematosus: Implications for Clinical Trial DesignMimi Kim, Joan Merrill, Kenneth Kalunian, et al.
Lupus Science & Medicine|November 14, 2023
Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and <i>Crithidia luciliae</i> assay in a multiethnic racial cohort of patients with SLEDevyn Zaminski, Amit Saxena, Peter Izmirly, et al.
Lupus Science & Medicine|October 14, 2024
Validating claims-based algorithms for a systemic lupus erythematosus diagnosis in Medicare data for informed use of the Lupus Index: a tool for geospatial researchCandace Feldman, Jeffrey R Curtis, Jim C Oates, et al.
Lupus Science & Medicine|May 14, 2019
SLE: reconciling heterogeneityMichael D Lockshin, Medha Barbhaiya, Peter Izmirly, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Rheumatology|May 1, 2023
Molnupiravir and Nirmatelvir/Ritonavir in the Treatment of Patients With Systemic Autoimmune Rheumatic Disease With SARS-CoV-2Kelly Corbitt, Peter Izmirly, Amit Saxena
Current Opinion in Rheumatology|May 19, 2017
Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupusPeter Izmirly, Amit Saxena, Jill P Buyon
Journal of the American Heart Association|June 22, 2022
To Be or Not to Be Treated: That Is the Question in Managing a Fetus With Cardiac Injury Exposed to Anti-SSA/RoJill Buyon, Amit Saxena, Deborah Friedman, et al.
Arthritis Care & Research|July 9, 2016
Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data SystemAnna Broder, Wenzhu B Mowrey, Peter Izmirly, et al.
Lupus Science & Medicine|October 16, 2018
Evaluating duration of response to treatment in systemic lupus erythematosus clinical trialsMimi Kim, Joan T Merrill, Kenneth Kalunian, et al.
AJP Reports|May 11, 2023
Autoimmune Congenital Complete Heart Block: How Late Can It Occur?Luv Makadia, Peter Izmirly, Jill P Buyon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
Brief Report: Longitudinal Patterns of Response to Standard of Care Therapy for Systemic Lupus Erythematosus: Implications for Clinical Trial DesignMimi Kim, Joan Merrill, Kenneth Kalunian, et al.
Lupus Science & Medicine|November 14, 2023
Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and <i>Crithidia luciliae</i> assay in a multiethnic racial cohort of patients with SLEDevyn Zaminski, Amit Saxena, Peter Izmirly, et al.
Lupus Science & Medicine|October 14, 2024
Validating claims-based algorithms for a systemic lupus erythematosus diagnosis in Medicare data for informed use of the Lupus Index: a tool for geospatial researchCandace Feldman, Jeffrey R Curtis, Jim C Oates, et al.
Lupus Science & Medicine|May 14, 2019
SLE: reconciling heterogeneityMichael D Lockshin, Medha Barbhaiya, Peter Izmirly, et al.
Pageof 7